vs
Side-by-side financial comparison of ARDELYX, INC. (ARDX) and MONARCH CASINO & RESORT INC (MCRI). Click either name above to swap in a different company.
MONARCH CASINO & RESORT INC is the larger business by last-quarter revenue ($136.6M vs $94.5M, roughly 1.4× ARDELYX, INC.). MONARCH CASINO & RESORT INC runs the higher net margin — 20.2% vs -39.8%, a 60.0% gap on every dollar of revenue. On growth, ARDELYX, INC. posted the faster year-over-year revenue change (27.5% vs 8.9%). Over the past eight quarters, ARDELYX, INC.'s revenue compounded faster (13.6% CAGR vs 3.2%).
Ardelyx, Inc. is a commercial-stage biopharmaceutical firm developing and commercializing innovative therapies for gastrointestinal, cardiorenal and metabolic diseases with high unmet medical needs. Its lead product is approved in the US for irritable bowel syndrome with constipation, and it holds a robust pipeline of early and late-stage drug candidates.
The Atlantis Casino Resort Spa is a hotel and casino located in Reno, Nevada, United States. It is owned and operated by Monarch Casino & Resort, Inc. Its three hotel towers have a combined 824 guest rooms and suites. The casino floor spans 64,814 sq ft. Often known simply as "Atlantis," it is one of Reno's most profitable and luxurious properties, competing directly with Peppermill Hotel Casino and Grand Sierra Resort for customers. Nearly $150 million has been spent on upgrading the facility.
ARDX vs MCRI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $94.5M | $136.6M |
| Net Profit | $-37.6M | $27.6M |
| Gross Margin | — | — |
| Operating Margin | — | 25.6% |
| Net Margin | -39.8% | 20.2% |
| Revenue YoY | 27.5% | 8.9% |
| Net Profit YoY | — | 38.9% |
| EPS (diluted) | $-0.15 | $1.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $94.5M | $136.6M | ||
| Q4 25 | $125.2M | $140.0M | ||
| Q3 25 | $110.3M | $142.8M | ||
| Q2 25 | $97.7M | $136.9M | ||
| Q1 25 | $74.1M | $125.4M | ||
| Q4 24 | $116.1M | $134.5M | ||
| Q3 24 | $98.2M | $137.9M | ||
| Q2 24 | $73.2M | $128.1M |
| Q1 26 | $-37.6M | $27.6M | ||
| Q4 25 | $-407.0K | $22.9M | ||
| Q3 25 | $-969.0K | $31.6M | ||
| Q2 25 | $-19.1M | $27.0M | ||
| Q1 25 | $-41.1M | $19.9M | ||
| Q4 24 | $4.6M | $4.2M | ||
| Q3 24 | $-809.0K | $27.6M | ||
| Q2 24 | $-16.5M | $22.7M |
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | 20.8% | ||
| Q3 25 | 96.4% | 26.7% | ||
| Q2 25 | 87.3% | 25.5% | ||
| Q1 25 | 83.4% | 20.2% | ||
| Q4 24 | 84.3% | 2.9% | ||
| Q3 24 | 84.0% | 25.6% | ||
| Q2 24 | 87.1% | 23.0% |
| Q1 26 | — | 25.6% | ||
| Q4 25 | 4.1% | 21.3% | ||
| Q3 25 | 4.2% | 27.1% | ||
| Q2 25 | -14.7% | 25.8% | ||
| Q1 25 | -49.0% | 20.4% | ||
| Q4 24 | 7.0% | 3.1% | ||
| Q3 24 | 2.3% | 25.5% | ||
| Q2 24 | -18.6% | 22.9% |
| Q1 26 | -39.8% | 20.2% | ||
| Q4 25 | -0.3% | 16.4% | ||
| Q3 25 | -0.9% | 22.1% | ||
| Q2 25 | -19.5% | 19.7% | ||
| Q1 25 | -55.5% | 15.8% | ||
| Q4 24 | 4.0% | 3.1% | ||
| Q3 24 | -0.8% | 20.0% | ||
| Q2 24 | -22.5% | 17.7% |
| Q1 26 | $-0.15 | $1.52 | ||
| Q4 25 | $-0.01 | $1.25 | ||
| Q3 25 | $0.00 | $1.69 | ||
| Q2 25 | $-0.08 | $1.44 | ||
| Q1 25 | $-0.17 | $1.05 | ||
| Q4 24 | $0.01 | $0.25 | ||
| Q3 24 | $0.00 | $1.47 | ||
| Q2 24 | $-0.07 | $1.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $238.1M | $120.1M |
| Total DebtLower is stronger | $203.5M | — |
| Stockholders' EquityBook value | $148.6M | $549.8M |
| Total Assets | $504.5M | $725.2M |
| Debt / EquityLower = less leverage | 1.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $238.1M | $120.1M | ||
| Q4 25 | $68.0M | — | ||
| Q3 25 | $42.7M | — | ||
| Q2 25 | $90.0M | — | ||
| Q1 25 | $30.8M | — | ||
| Q4 24 | $64.9M | — | ||
| Q3 24 | $47.4M | — | ||
| Q2 24 | $41.9M | — |
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | — | ||
| Q3 25 | $202.1M | — | ||
| Q2 25 | $201.4M | — | ||
| Q1 25 | $151.3M | — | ||
| Q4 24 | $150.9M | — | ||
| Q3 24 | $100.7M | — | ||
| Q2 24 | $100.2M | — |
| Q1 26 | $148.6M | $549.8M | ||
| Q4 25 | $166.9M | $537.7M | ||
| Q3 25 | $154.3M | $558.4M | ||
| Q2 25 | $139.5M | $539.2M | ||
| Q1 25 | $145.7M | $535.6M | ||
| Q4 24 | $173.3M | $517.7M | ||
| Q3 24 | $158.3M | $513.3M | ||
| Q2 24 | $147.0M | $498.4M |
| Q1 26 | $504.5M | $725.2M | ||
| Q4 25 | $501.6M | $712.8M | ||
| Q3 25 | $486.2M | $725.4M | ||
| Q2 25 | $466.8M | $705.8M | ||
| Q1 25 | $410.2M | $712.1M | ||
| Q4 24 | $435.8M | $691.6M | ||
| Q3 24 | $367.9M | $671.1M | ||
| Q2 24 | $343.5M | $672.4M |
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.44× | — | ||
| Q1 25 | 1.04× | — | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
MCRI
| Casino | $79.7M | 58% |
| Food and beverage | $31.7M | 23% |
| Hotel | $19.0M | 14% |
| Other | $6.1M | 5% |
